PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level. (2019)

First Author: Banerji CRS
Attributed to:  Understanding and Ameliorating Pathogenesis in FSHD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddz043

PubMed Identifier: 31067297

Publication URI: http://europepmc.org/abstract/MED/31067297

Type: Journal Article/Review

Volume: 28

Parent Publication: Human molecular genetics

Issue: 13

ISSN: 0964-6906